The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Current approaches to exploit actinomycetes as a source of novel natural products
Open accessAbstract
For decades, microbial natural products have been one of the major sources of novel drugs for pharmaceutical companies, and today all evidence suggests that novel molecules with potential therapeutic applications are still waiting to be discovered from these natural sources, especially from actinomycetes. Any appropriate exploitation of the chemical diversity of these microbial sources relies on proper understanding of their biological diversity and other related key factors that maximize the possibility of successful identification of novel molecules. Without doubt, the discovery of platensimycin has shown that microbial natural products can continue to deliver novel scaffolds if appropriate tools are put in place to reveal them in a cost-effective manner. Whereas today innovative technologies involving exploitation of uncultivated environmental diversity, together with chemical biology and in silico approaches, are seeing rapid development in natural products research, maximization of the chances of exploiting chemical diversity from microbial collections is still essential for novel drug discovery. This work provides an overview of the integrated approaches developed at the former Basic Research Center of Merck Sharp and Dohme in Spain to exploit the diversity and biosynthetic potential of actinomycetes, and includes some examples of those that were successfully applied to the discovery of novel antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Cited by
Diversity and Natural Functions of Antibiotics Produced by Beneficial and Plant Pathogenic Bacteria
Raaijmakers, J. M., & Mazzola, M. (2012) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-081211-172908 · Cited by 674
Actinomycetes: Still a source of novel antibiotics
Genilloud, O. (2017) · Natural Product Reports · doi:10.1039/c7np00026j · Cited by 465
Self-citationOne-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces
Huang, H., Zheng, G., Jiang, W., Hu, H., & Lu, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv007 · Cited by 289
Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?
Bachmann, B. O., Van Lanen, S. G., & Baltz, R. H. (2014) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-013-1389-9 · Cited by 276
Hubert, J., Nuzillard, J.-M., & Renault, J.-H. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-015-9448-7 · Cited by 273
Metadata
- Authors
- Genilloud, O., González, I., Salazar, O., Martín, J., Tormo, J. R., & Vicente, F.
- Venue
- Journal of Industrial Microbiology & Biotechnology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-08
- Volume
- 38
- Issue
- 3
- Pages
- 375-389
- ISSN
- 1367-5435 (ISSN-L)
- 1476-5535
- OpenAlex
- W2079005811
- Cited by
- 203
- References
- 2
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current approaches to exploit actinomycetes as a source of novel natural products. https://app.cochat.ai/papers/10.1007/s10295-010-0882-7
- The paper
- Genilloud, O., González, I., Salazar, O., Martín, J., Tormo, J. R., & Vicente, F. (2011). Current approaches to exploit actinomycetes as a source of novel natural products. Journal of Industrial Microbiology & Biotechnology. https://doi.org/10.1007/s10295-010-0882-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.